KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Supernus Pharmaceuticals (SUPN) Non Operating Investment Income: 2012-2017

Historic Non Operating Investment Income for Supernus Pharmaceuticals (SUPN) over the last 5 years, with Jun 2017 value amounting to $23,000.

  • Supernus Pharmaceuticals' Non Operating Investment Income fell 81.30% to $23,000 in Q2 2017 from the same period last year, while for Jun 2017 it was $301,000, marking a year-over-year decrease of 35.27%. This contributed to the annual value of $76,000 for FY2017, which is 83.04% down from last year.
  • Supernus Pharmaceuticals' Non Operating Investment Income amounted to $23,000 in Q2 2017, which was down 57.41% from $54,000 recorded in Q1 2017.
  • Supernus Pharmaceuticals' 5-year Non Operating Investment Income high stood at $760,000 for Q3 2014, and its period low was -$8.6 million during Q2 2013.
  • In the last 3 years, Supernus Pharmaceuticals' Non Operating Investment Income had a median value of $100,000 in 2016 and averaged $71,800.
  • Per our database at Business Quant, Supernus Pharmaceuticals' Non Operating Investment Income slumped by 2,527.74% in 2013 and then spiked by 12,200.00% in 2016.
  • Quarterly analysis of 5 years shows Supernus Pharmaceuticals' Non Operating Investment Income stood at -$662,000 in 2013, then surged by 204.83% to $694,000 in 2014, then crashed by 81.70% to $127,000 in 2015, then decreased by 22.05% to $99,000 in 2016, then crashed by 81.30% to $23,000 in 2017.
  • Its Non Operating Investment Income was $23,000 in Q2 2017, compared to $54,000 in Q1 2017 and $99,000 in Q4 2016.